TAYSHA GENE THERAPIES INC (TSHA) Institutional Ownership

TSHA is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $3.33M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

The largest disclosed holder is Polen Capital Management, which reported ownership valued at approximately $3.33M in its June 30, 2026 13F filing. Based on current market prices and the latest disclosed share count, Polen Capital Management's TSHA position is now estimated to be worth approximately $2.52M, representing an estimated loss of -24.23% since the filing period.

Major shareholders tracked on this page include Polen Capital Management, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward TAYSHA GENE THERAPIES INC (TSHA).